188 related articles for article (PubMed ID: 34572837)
1. Metformin Potentiates the Anticancer Effect of Everolimus on Cervical Cancer In Vitro and In Vivo.
Chen YH; Wu JX; Yang SF; Chen ML; Chen TH; Hsiao YH
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572837
[TBL] [Abstract][Full Text] [Related]
2. Combining metformin and nelfinavir exhibits synergistic effects against the growth of human cervical cancer cells and xenograft in nude mice.
Xia C; Chen R; Chen J; Qi Q; Pan Y; Du L; Xiao G; Jiang S
Sci Rep; 2017 Mar; 7():43373. PubMed ID: 28252027
[TBL] [Abstract][Full Text] [Related]
3. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
[TBL] [Abstract][Full Text] [Related]
4. Metformin induces apoptosis and inhibits migration by activating the AMPK/p53 axis and suppressing PI3K/AKT signaling in human cervical cancer cells.
Chen YH; Yang SF; Yang CK; Tsai HD; Chen TH; Chou MC; Hsiao YH
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236135
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of everolimus in combination with paclitaxel on adriamycin-resistant breast cancer cell line MDA-MB-231.
Xu T; Liu P; Li Q; Shi C; Wang X
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):828-834. PubMed ID: 33218396
[TBL] [Abstract][Full Text] [Related]
6. Combined Use of Metformin and Everolimus Is Synergistic in the Treatment of Breast Cancer Cells.
Wang Y; Wei J; Li L; Fan C; Sun Y
Oncol Res; 2014; 22(4):193-201. PubMed ID: 26351208
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Combination of Luteolin and Asiatic Acid on Cervical Cancer In Vitro and In Vivo.
Chen YH; Wu JX; Yang SF; Hsiao YH
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672499
[TBL] [Abstract][Full Text] [Related]
8. Metformin synergistically enhances antitumor activity of cisplatin in gallbladder cancer via the PI3K/AKT/ERK pathway.
Bi T; Zhu A; Yang X; Qiao H; Tang J; Liu Y; Lv R
Cytotechnology; 2018 Feb; 70(1):439-448. PubMed ID: 29110119
[TBL] [Abstract][Full Text] [Related]
9. Pitavastatin and metformin synergistically activate apoptosis and autophagy in pancreatic cancer cells.
Chen YH; Huang YC; Yang SF; Yen HH; Tsai HD; Hsieh MC; Hsiao YH
Environ Toxicol; 2021 Aug; 36(8):1491-1503. PubMed ID: 33886150
[TBL] [Abstract][Full Text] [Related]
10. Synergic Effect of Metformin and Everolimus on Mitochondrial Dynamics of Renal Cell Carcinoma.
Hong SH; Lee KS; Hwang HJ; Park SY; Han WK; Yoon YE
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35885994
[TBL] [Abstract][Full Text] [Related]
11. Everolimus decreases [U-
Ariaans G; Tiersma JF; Evers B; Gerding A; Waaijer SJH; Koster RA; Touw DJ; Bakker BM; Reijngoud DJ; de Jong S; Jalving M
Biomed Pharmacother; 2024 Apr; 173():116362. PubMed ID: 38432130
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy Eve and Pac to induce apoptosis in cervical cancer cells by targeting PI3K/AKT/mTOR pathways.
Dong P; Hao F; Dai S; Tian L
J Recept Signal Transduct Res; 2018 Feb; 38(1):83-88. PubMed ID: 29369007
[TBL] [Abstract][Full Text] [Related]
13. Metformin and Everolimus: A Promising Combination for Neuroendocrine Tumors Treatment.
Vitali E; Boemi I; Tarantola G; Piccini S; Zerbi A; Veronesi G; Baldelli R; Mazziotti G; Smiroldo V; Lavezzi E; Spada A; Mantovani G; Lania AG
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32748870
[TBL] [Abstract][Full Text] [Related]
14. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
Li C; Liu VW; Chan DW; Yao KM; Ngan HY
Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression.
Xia C; Liu C; He Z; Cai Y; Chen J
J Exp Clin Cancer Res; 2020 Jul; 39(1):127. PubMed ID: 32631421
[TBL] [Abstract][Full Text] [Related]
16. Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models.
Zi FM; He JS; Li Y; Wu C; Yang L; Yang Y; Wang LJ; He DH; Zhao Y; Wu WJ; Zheng GF; Han XY; Huang H; Yi Q; Cai Z
Cancer Lett; 2015 Jan; 356(2 Pt B):443-53. PubMed ID: 25305450
[TBL] [Abstract][Full Text] [Related]
17. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
18. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
[TBL] [Abstract][Full Text] [Related]
19.
Wang D; Wu X
Oncol Lett; 2015 Aug; 10(2):975-981. PubMed ID: 26622608
[TBL] [Abstract][Full Text] [Related]
20. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
